PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 1, 2017Cancer Epidemiology Biomarkers & Prevention194 citationsOpen Access

The Obesity Paradox in Cancer—Moving Beyond BMI

View Full Paper
SSShlomit Strulov ShacharGWGrant R. Williams

Key Points

Key points are not available for this paper at this time.

Abstract

Body mass index (BMI) and simple counts of weight are easy and available tools in the clinic and in research. Recent studies have shown that cancer patients with a low normal BMI (or those with weight loss) have worse outcomes than obese patients. These results suggest that obesity has a protective effect and has been termed the "obesity paradox." In this commentary, we discuss hypothetical explanations and take a step beyond BMI or simple weights alone to present other useful and more specific body composition metrics, such as muscle tissue mass, visceral fat mass, and subcutaneous fat mass. Body composition is highly variable between individuals with significant differences seen between various races and ages. Therefore, it is critical to consider that patients with the exact same BMI can have significantly different body compositions and different outcomes. We encourage further studies to examine body composition beyond BMI and to use other body composition metrics to develop individualized treatments and intervention strategies. Cancer Epidemiol Biomarkers Prev; 26(1); 13-16. ©2017 AACR SEE ALL THE ARTICLES IN THIS CEBP FOCUS SECTION, "THE OBESITY PARADOX IN CANCER EVIDENCE AND NEW DIRECTIONS".

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Shachar et al. (2017) studied this question.

synapsesocial.com/papers/69dd4d910a7b4bc8c410153dhttps://doi.org/10.1158/1055-9965.epi-16-0439
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Sarcopenia as a Determinant of Chemotherapy Toxicity and Time to Tumor Progression in Metastatic Breast Cancer Patients Receiving Capecitabine Treatment2009 · 1,127 citations
  2. 2Smoking, body weight, and their effects on smoking behavior: A comprehensive review of the literature.1989 · 488 citations
  3. 3Factors involved in the paradox of reverse epidemiology2014 · 4 citations
  4. 4Mechanisms of metabolic dysfunction in cancer-associated cachexia2016 · 361 citations
  5. 5Delay in chemotherapy administration impacts survival in elderly patients with epithelial ovarian cancer2015 · 67 citations